People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
Patients with head and neck cancer often face physical, social and emotional issues that can add to existing mental health problems or give rise to new ones.
A caregiver offers tips for staying on top of appointments and test results when a loved one is receiving care from multiple providers.
Steven Rosenberg explains his work trying to treat cancer with tumor infiltrating lymphocytes.
The U.S. Food and Drug Administration approves three new treatments for acute myeloid leukemia.
Researchers investigate how the microbiome affects immune response patterns in colorectal tumors.
Janet Freeman-Daily: On Lung Cancer and Blame
donate to the AACR
The AACR Cancer Progress Report 2018, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.